Ignite Creation Date:
2024-05-06 @ 1:29 AM
Last Modification Date:
2024-10-26 @ 11:05 AM
Study NCT ID:
NCT01829659
Status:
COMPLETED
Last Update Posted:
2018-06-08
First Post:
2013-04-09
Brief Title:
The ACS Ethnicity Platelet Function Study
Sponsor:
Medstar Health Research Institute
Organization:
Medstar Health Research Institute
Study Overview
Official Title:
The ACS Ethnicity Platelet Function Study
Status:
COMPLETED
Status Verified Date:
2018-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is being done to assess the effects of the CTP inhibitor on the function of your platelets cells within your blood that are involved in the formation of blood clots and to assess whether you have responded to the ticagrelor well enough to prevent the formation of blood clots within the stent or site in which angioplasty was performed
Recent studies have looked at how racial differences can affect platelet reactivity the way blood clots But these studies have not looked at the way different racial backgrounds can affect the way the blood forms clots Minorities such as African-Americans are underrepresented Therefore we are conducting this platelet reactivity study to better understand if there are differences in how this drug affects African-Americans from how they affect Caucasian patients undergoing percutaneous coronary intervention and receiving ticagrelor These data will be compared to a historical control of Caucasian patients who underwent similar platelet function testing
Recent studies have looked at how racial differences can affect platelet reactivity the way blood clots But these studies have not looked at the way different racial backgrounds can affect the way the blood forms clots Minorities such as African-Americans are underrepresented Therefore we are conducting this platelet reactivity study to better understand if there are differences in how this drug affects African-Americans from how they affect Caucasian patients undergoing percutaneous coronary intervention and receiving ticagrelor These data will be compared to a historical control of Caucasian patients who underwent similar platelet function testing
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None